|
|
||||||||
From the Departments of Ophthalmology (Drs. Biousse, Skibell, and Newman, D.N. Loupe), Neurology (Drs. Biousse and Newman), Neurological Surgery (Dr. Newman), and Epidemiology (Dr. Drews-Botsch), Emory University, Atlanta, and Department of Neurology (Dr. Watts), University of Alabama, Birmingham, AL.
Address correspondence and reprint requests to Dr. V. Biousse, Neuro-Ophthalmology Unit, Emory Eye Center, 1365-B Clifton Rd., Atlanta, GA 30322; e-mail: vbiouss{at}emory.edu
Patients with Parkinsons disease (PD) commonly complain of impaired visual function and difficulty reading, despite normal visual acuity. Although previous studies have evaluated contrast sensitivity, color vision, visuospatial processing, visual hallucinations, and ocular movements, none has systematically evaluated the ocular complaints and ocular findings of PD patients. Thirty patients with early untreated PD and 31 control subjects without neurologic or known ocular diseases were ophthalmologically evaluated for the frequency of visual complaints, dry eyes, blepharitis, visual hallucinations, reduced blink rate, blepharospasm, and convergence insufficiency. Ocular complaints suggesting ocular surface irritation, altered tear film, visual hallucinations, blepharospasm, decreased blink rate, and decreased convergence amplitudes were more common in PD patients than in control subjects. These findings likely account for many of the visual difficulties commonly encountered by PD patients. These ocular abnormalities frequently respond to treatment.
Received May 29, 2003. Accepted in final form August 13, 2003.
Presented in part at the American Academy of Neurology, March 2003, Honolulu, HI.
This article has been cited by other articles:
![]() |
A. H. Friedlander, M. Mahler, K. M. Norman, and R. L. Ettinger Parkinson Disease: Systemic and Orofacial Manifestations, Medical and Dental Management J Am Dent Assoc, June 1, 2009; 140(6): 658 - 669. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Archibald, M. P. Clarke, U. P. Mosimann, and D. J. Burn The retina in Parkinson's disease Brain, May 1, 2009; 132(5): 1128 - 1145. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Jankovic Parkinson's disease: clinical features and diagnosis J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 368 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Arnoldi and J. D. Reynolds A Review of Convergence Insufficiency: What Are We Really Accomplishing with Exercises? Amer. Orthoptic Jrnl., January 1, 2007; 57(1): 123 - 130. [Abstract] [PDF] |
||||
![]() |
A. Kesler and A. D Korczyn Visual disturbances in Parkinson's disease Practical Neurology, February 1, 2006; 6(1): 28 - 33. [Full Text] [PDF] |
||||
![]() |
G. Fenelon, C. G. Goetz, and A. Karenberg Hallucinations in Parkinson disease in the prelevodopa era Neurology, January 10, 2006; 66(1): 93 - 98. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Tomsak, R. B. Daroff, J. H. Friedman, V. Biousse, and N. J. Newman Ophthalmologic features of Parkinson's disease Neurology, September 14, 2004; 63(5): 940 - 941. [Full Text] [PDF] |
||||
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |